A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
- Citation:
- Oncologist vol 25 (6) 523-531
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 9
- Parents:
- 738
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180866, U10CA180790, UG1CA189872
- Corr. Author:
- Authors:
- Kaushal Parikh Sumithra J. Mandrekar Katie Allen‐Ziegler Brandt Esplin Angelina D. Tan Benjamin Marchello Alex A. Adjei Julian R. Molina
- Networks:
- LAPS-MN026, UT056
- Study
- NCCTG-N0623
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Pazopanib, Phase II, Malignant, Pleural mesothelioma